Aprea Therapeutics, Inc.

Q1 2021 13F Holders

Symbol
APRE
CUSIP
03836J102
Type
Equity
Class
COM
Num filers
70
Total reported value, excl. options
$45.4M
Manager Report Date Value ($000) Shares